Please use this identifier to cite or link to this item: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1178994
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNOBRE, M. R.eng
dc.contributor.authorPINTO, D. dos S. C.eng
dc.contributor.authorLOURES, M. D. de A.eng
dc.contributor.authorLÉPORI, C.eng
dc.contributor.authorFERRANTE, M.eng
dc.contributor.authorBRANDAO, H. de M.eng
dc.date.accessioned2025-09-22T16:48:49Z-
dc.date.available2025-09-22T16:48:49Z-
dc.date.created2025-09-22
dc.date.issued2025
dc.identifier.citationIn: CONFERENCE OF THE WORLD ASSOCIATION FOR THE ADVANCEMENTS OF VETERINARY PARASITOLOGY, 30., 2025, Curitiba. Abstract book. Curitiba: Universidade Federal do Paraná, 2025.
dc.identifier.urihttp://www.alice.cnptia.embrapa.br/alice/handle/doc/1178994-
dc.descriptionTrichomonosis is a venereal disease of cattle caused by the flagellated protozoan Tritrichomonas fetus. In males, the protozoan is found in the mucosa of the preputial cavity, and in older animals, the increase in the size of the preputial crypts creates a microenvironment conducive to the survival of the pathogen.
dc.language.isoeng
dc.rightsopenAccess
dc.titleDevelopment of a nanocarrier pharmaceutical formulation containing metronidazole for the topical treatment of bovine trichomoniasis.
dc.typeResumo em anais e proceedings
dc.subject.thesagroBovino
dc.subject.thesagroDoença Animal
dc.subject.thesagroTricomonose
dc.format.extent2p. 357.
riaa.ainfo.id1178994
riaa.ainfo.lastupdate2025-09-22
dc.contributor.institutionMATHEUS RESENDE NOBRE, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionDANIELLE DOS SANTOS CINELLI PINTO, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionMICHELLE DAIANE DE ALMEIDA LOURES, CNPGLeng
dc.contributor.institutionCRISTIAN LÉPORI, UNIVERSIDADE NACIONAL DE RIO CUARTOeng
dc.contributor.institutionMARCOS FERRANTE, UNIVERSIDADE FEDERAL DE LAVRASeng
dc.contributor.institutionHUMBERTO DE MELLO BRANDAO, CNPGL.eng
Appears in Collections:Resumo em anais de congresso (CNPGL)

Files in This Item:
File Description SizeFormat 
Development-of-a-nanocarrier-pharmaceutical-formulation.pdf460,93 kBAdobe PDFThumbnail
View/Open
Show simple item record

FacebookTwitterDeliciousLinkedInGoogle BookmarksMySpace